metricas
covid
Buscar en
Radiología (English Edition)
Toda la web
Inicio Radiología (English Edition) Treatment of benign biliary leaks with transhepatic placement of coated self-exp...
Journal Information
Vol. 59. Issue 1.
Pages 47-55 (January - February 2017)
Share
Share
Download PDF
More article options
Visits
161
Vol. 59. Issue 1.
Pages 47-55 (January - February 2017)
Original article
Treatment of benign biliary leaks with transhepatic placement of coated self-expanding metallic stents
Tratamiento de fugas biliares mediante colocación transparietohepática de endoprótesis metálicas recubiertas
Visits
161
M. Páramoa,
Corresponding author
mparamo@unav.es

Corresponding author.
, P. García-Barquína, M. Carrillob, M. Millor Muruzábala, I. Vivasa, J.I. Bilbaoa
a Departamento de Radiología, Clínica Universidad de Navarra, Pamplona, Navarra, Spain
b Departamento de Radiología, Hospital Morales Meseguer, Murcia, Spain
This item has received
Article information
Abstract
Full Text
Bibliography
Download PDF
Statistics
Figures (4)
Show moreShow less
Tables (2)
Table 1. Characteristics of patients treated through coated self-expanding metallic stents.
Table 2. Percutaneous biliary proceedings.
Show moreShow less
Abstract
Objectives

To analyze the safety and efficacy of percutaneous placement of coated self-expanding metallic stents (SEMS) in patients with biliary leaks.

Material and methods

This ethics committee at our center approved this study. We retrospectively reviewed all coated SEMS placed between October 2008 and September 2015. We analyzed patient-related factors such as the primary underlying disease, prior hepatic procedures, and clinical outcome. We evaluated the location, the number and type of leak (anastomotic or non-anastomotic), and the characteristics of the interventional procedure (number of stents deployed, location of the stents, technical success, and primary functionality). We recorded the complications registered.

Results

We studied 14 patients (11 men and 3 women). The mean follow-up period was 375.5 days (range 15–1920 days). Leaks were postsurgical in 12 patients. One patient developed an arteriobilioportal fistula. In another, the biliary leak occurred secondary to the rupture of the common bile duct after ERCP. A total of 23 coated SEMS were placed, including 21 Fluency® stents (Bard, Tempe, AZ, USA) and 2 Wallflex® stents (Boston Scientific, Galway, Republic of Ireland). The technical success of the procedure was considered total in 11 (78.6%) patients, partial in 2 (14.3%) patients, and null in 1 (7.2%) patient. The clinical outcome was good in 13 of the 14 patients. The mean period of primary functionality of the coated SEMS was 331 days (range 15–1920 days). No major complications were observed in 11 (78.6%) patients.

Conclusions

Percutaneous placement of coated SEMS for the treatment of benign biliary leaks is safe and efficacious, with a high rate of technical and clinical success and a moderate rate of complications.

Keywords:
Biliary leak
Coated stent
Patency
Technical success
Clinical success
Resumen
Objetivo

Analizar la seguridad y eficacia en el uso percutáneo de endoprótesis metálicas autoexpandibles recubiertas (EMAR) en pacientes con fuga biliar.

Material y métodos

Este estudio ha sido aprobado por el Comité de Ética de nuestro centro. Se realizó una revisión retrospectiva de las EMAR colocadas entre octubre de 2008 y septiembre de 2015. Se analizaron la enfermedad primaria subyacente, los procedimientos hepáticos previos y el éxito clínico. Se evaluó la localización, el número, el tipo de fuga y las características del procedimiento intervencionista (número de prótesis empleadas, localización, éxito técnico y funcionalidad primaria). Se recogieron las complicaciones registradas.

Resultados

Se estudiaron 14 pacientes. El seguimiento medio fue de 375,5 días (rango de 15-1920 días). En 12 pacientes las fugas biliares fueron posquirúrgicas. Un paciente presentó una fístula arteriobilioportal. En otro paciente, la fuga biliar fue post-CPRE. Se colocaron un total de 23 EMAR: 21 prótesis tipo Fluency® (Bard, Tempe, Arizona, EE.UU.) y dos prótesis tipo Wallflex® (Boston Scientific, Galway, Irlanda). Se consiguió éxito técnico total en el 78,6% (n=11), parcial en el 14,3% (n=2) y no se obtuvo éxito en el 7,2% (n=1). Se consiguió éxito clínico en 13 de 14 pacientes. La media de funcionalidad primaria de las EMAR fue de 331 días (rango de 15-1920 días). Once pacientes no presentaron ninguna complicación mayor.

Conclusiones

La colocación percutánea de EMAR es un método seguro y eficaz en el tratamiento de fugas biliares benignas, con una alta tasa de éxito técnico y clínico y un nivel moderado de complicaciones.

Palabras clave:
Fuga biliar
Prótesis recubiertas
Permeabilidad
Éxito técnico
Éxito clínico

Article

These are the options to access the full texts of the publication Radiología (English Edition)
Subscriber
Subscriber

If you already have your login data, please click here .

If you have forgotten your password you can you can recover it by clicking here and selecting the option “I have forgotten my password”
Purchase
Purchase article

Purchasing article the PDF version will be downloaded

Price 19.34 €

Purchase now
Contact
Phone for subscriptions and reporting of errors
From Monday to Friday from 9 a.m. to 6 p.m. (GMT + 1) except for the months of July and August which will be from 9 a.m. to 3 p.m.
Calls from Spain
932 415 960
Calls from outside Spain
+34 932 415 960
E-mail
Article options
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos

Quizás le interese:
10.1016/j.rxeng.2021.09.010
No mostrar más